Voraxaze®

BTG International Inc.

Voraxaze®

Voraxaze® rapidly cleaves MTX into 2 inactive metabolites to provide a nonrenal pathway for elimination.

Medication Management Drugs

Do you know anyone using Voraxaze®?

Voraxaze® is a carboxypeptidase indicated to reduce toxic plasma methotrexate concentration in adult and pediatric patients with delayed methotrexate clearance due to impaired renal function. Voraxaze® is not recommended for use in patients who exhibit the expected clearance and expected plasma methotrexate concentration.

Voraxaze®